| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b5d728d4890268356fcc07e6e53840c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2006-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc438d118fa78928900c713579075bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabba7c3bb729162d2eb7d4dea3d1a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62458bb062c404c65f74410c23f157d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c5ef4a457ef7e2c44da1693a22f3a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af6f757c5cdfa54f9aa5261c62254aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73c918c0fb191435e49ecedba621c5c |
| publicationDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011064803-A1 |
| titleOfInvention |
Nanoparticulate and controlled release compositions comprising vitamin k2 |
| abstract |
The present invention is directed to compositions comprising a nanoparticulate vitamin K2 having improved bioavailability. The nanoparticulate vitamin K2 particles of the composition have an effective average particle size of less than about 2000 nm and are useful in the prevention and treatment of osteoporosis. The invention also relates to a controlled release composition comprising a vitamin K2 or a nanoparticulate vitamin K2 that in operation delivers the drug in a pulsed or multi-modal manner for the prevention and treatment of osteoporosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011146583-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014314867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014314856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014314862-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9381160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9271938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014010894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9931344-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737524-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10507186-B2 |
| priorityDate |
2005-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |